World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
54
Citations
10598
World Ranking
3956
National Ranking
147

Overview

Kees Brinkman is affiliated with the University of Amsterdam in the Netherlands, where their research focuses primarily on the field of Medicine, with particular expertise in Infectious Diseases, Epidemiology, Virology, Neurology, and Hepatology.

Their scholarly output includes significant contributions to topics such as:

  • HIV/AIDS Research and Interventions
  • HIV, Drug Use, Sexual Risk
  • HIV/AIDS drug development and treatment
  • COVID-19 Clinical Research Studies
  • HIV Research and Treatment
  • Long-Term Effects of COVID-19
  • Hepatitis C virus research

Brinkman's recent publications include:

  • The effects of autonomous sensory meridian response (ASMR) on mood, attention, heart rate, skin conductance and EEG in healthy young adults, 2022, Experimental Brain Research
  • Incidence of HCV Reinfection Among HIV-Positive MSM and Its Association With Sexual Risk Behavior: A Longitudinal Analysis, 2020, Clinical Infectious Diseases
  • HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study, 2020, The Lancet HIV
  • Role of Self-Stigma in Pathways from HIV-Related Stigma to Quality of Life Among People Living with HIV, 2021, AIDS Patient Care and STDs
  • Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study, 2022, PLoS Medicine

Frequent co-authors in Brinkman's research include:

  • Marc van der Valk
  • Bart Rijnders
  • Casper Rokx
  • Maria Prins
  • Peter Reiss

Their work has been published in several prominent scientific venues, with repeated contributions to:

  • AIDS
  • BMJ Open
  • PLoS ONE
  • Clinical Infectious Diseases
  • Open Forum Infectious Diseases

Best Publications

  • Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

    Kees Brinkman;Jan A Smeitink;Johannes A Romijn;Peter Reiss

  • Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway.

    K. Brinkman;H.J.M. ter Hofstede;D.M. Burger;J.A.M. Smeitink

  • Future challenges for clinical care of an ageing population infected with HIV: a modelling study

    Mikaela Smit;Kees Brinkman;Suzanne Geerlings;Colette Smit

  • Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals

    Ard I. van Sighem;Luuk A. J. Gras;Peter Reiss;Kees Brinkman

  • Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission

    Thijs J.W. Van De Laar;Akke K. Van Der Bij;Maria Prins;Sylvia M. Bruisten

  • Mortality and progression to AIDS after starting highly active antiretroviral therapy.

    van Ai Sighem;van de Ma Mark Wiel;AC Ghani;M Jambroes

  • Feasibility and Effectiveness of Indicator Condition-Guided Testing for HIV: Results from HIDES I (HIV Indicator Diseases across Europe Study)

    Ann K. Sullivan;Dorthe Raben;Joanne Reekie;Michael Rayment

  • Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program

    Andrea Antinori;Gabriele Arendt;Igor Grant

  • Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice

    Mark G.J. de Boer;Guido E.L. van den Berk;Natasja van Holten;Josephine E. Oryszcyn

  • Aspergillus Meningitis: Diagnosis by Non-Culture-Based Microbiological Methods and Management

    Paul E. Verweij;Kees Brinkman;Herbert P. H. Kremer;Bart-Jan Kullberg

  • Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM.

    Femke A.E. Lambers;Maria Prins;Xiomara Thomas;Richard Molenkamp

  • Low plasma concentrations of indinavir are related to virological treatment failure in HIV-1-infected patients on indinavir-containing triple therapy.

    David M Burger;Richard Mw Hoetelmans;Patricia Wh Hugen;Jan W Mulder

  • Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals.

    David Burger;Patricia W. Hugen;Peter Reiss;Inge Gyssens

  • Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: a looming obstacle for long-term antiretroviral therapy?

    Unknown

  • First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir.

    Marit G A van Vonderen;Paul Lips;Michiel A van Agtmael;Elly A M Hassink

  • Risk Factors for Sexual Transmission of Hepatitis C Virus Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men: A Case-Control Study.

    Joost W Vanhommerig;Femke A E Lambers;Janke Schinkel;Ronald B Geskus

  • HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.

    Radjin Steingrover;Katalyn Pogány;Evian Fernandez Garcia;Suzanne Jurriaans

  • No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial

    Marlous L. Grijsen;Radjin Steingrover;Ferdinand W. N. M. Wit;Suzanne Jurriaans

  • Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA cohort.

    Jeanne P. Dieleman;Marielle Jambroes;Inge C. Gyssens;Miriam C. J. M. Sturkenboom

  • Clinical features and risk factors of lactic acidosis following long-term antiretroviral therapy: 4 fatal cases.

    H.J.M. ter Hofstede;S. de Marie;N.A. Foudraine;S.A. Danner

  • Carbamazepine–Indinavir Interaction Causes Antiretroviral Therapy Failure

    Patricia Wh Hugen;David M Burger;Kees Brinkman;Hadewych Jm ter Hofstede

  • Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996-2014: results from a national observational cohort.

    Eline L M Op de Coul;Ard van Sighem;Kees Brinkman;Birgit H van Benthem

  • Discontinuation of nevirapine because of hypersensitivity reactions in patients with prior treatment experience, compared with treatment-naive patients: the ATHENA cohort study

    Ferdinand W. N. M. Wit;Anouk M. Kesselring;Luuk Gras;Clemens Richter

Frequent Co-Authors

Peter Reiss
Peter Reiss University of Amsterdam
Jan M. Prins
Jan M. Prins University of Amsterdam
David M. Burger
David M. Burger Radboud University
Maria Prins
Maria Prins University of Amsterdam
Janke Schinkel
Janke Schinkel University of Amsterdam
Suzanne Jurriaans
Suzanne Jurriaans University of Amsterdam
Richard Molenkamp
Richard Molenkamp Erasmus University Rotterdam
Joep M. A. Lange
Joep M. A. Lange University of Amsterdam
William A. Paxton
William A. Paxton University of Liverpool
Andy I. M. Hoepelman
Andy I. M. Hoepelman Utrecht University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open diverse career opportunities in healthcare and research. Many choose programs like the accredited fast medical billing and coding certificate online, which offers a quick entry into the medical administration field, complementing scientific knowledge with practical healthcare skills.

Furthermore, a variety of online healthcare programs provide flexible learning options for those aiming to advance their qualifications without interrupting their professional lives. Such programs include nursing, health information management, and public health, creating pathways that align well with a microbiology background.

Public health professionals with a microbiology foundation often pursue the easiest MPH online programs to get into to deepen their understanding of disease prevention and control. These programs tend to feature streamlined admissions, making them accessible for many aspiring students.

Additionally, roles like child life specialists show the intersection of healthcare and patient support, offering rewarding career options. Interested individuals can explore the child life specialist salary and job outlook to assess the benefits of this profession alongside their science background.

Best Scientists Citing Kees Brinkman

Trending Scientists